KTU research team and partners to use artificial intelligence to diagnose deep vein thrombosis

Important | 2024-03-12

Kaunas University of Technology Biomedical Engineering Institute (KTU BMEI) is launching a new project ThrombUS+, which focuses on continuous monitoring of deep vein thrombosis, assessment of potential risks and prevention. The project will be carried out by 18 partners from 7 European countries and the USA, coordinated by the research organisation Athina (Greece).

In addition to KTU, the project will be carried out in Lithuania by clinical partners – Lithuanian University of Health Sciences (project leader Prof. Andrius Macas) and technology partner Telemed (project leader Dmitrij Novikov). The project duration is expected to be 42 months and the budget is EUR 9.5 million, funded by the European Union’s European Horizon programme.

According to Prof. Vaidotas Marozas, Director of the BMEI, deep vein thrombosis is a condition in which blood clots form in the deep veins, often in the legs, which, when they break off, can block the blood vessels of the lungs, causing a life-threatening pulmonary embolism. Diagnosis of this pathology is complicated primarily by the absence of symptoms.

“This project aims to solve the problem of diagnosis and prevention by using a wearable device – a system that uses artificial intelligence algorithms to analyse data recorded by ultrasound, plethysmography and light reflection rheography sensors. The system will help to prevent deep vein thrombosis by monitoring the activity of bedridden patients’ limbs while they play mobility-enhancing special-purpose computer games,” says the project leader, Professor Vaidotas Marozas of KTU.

Director of KTU Biomedical Engineering Institute

The ThrombUS+ project aims to collect and use big data to train and test artificial intelligence algorithms. Large-scale clinical trials are also planned.

KTU BMEI has extensive experience in the development of biomedical sensors, signal processing algorithms, as well as in the development and registration of biosignal databases, and will be responsible for the integration of the sensors into the system for the work package.

Scientists have also unveiled a revolutionary medical bracelet that can automatically diagnose atrial fibrillation arrhythmia. Teltonika Telemedic has acquired a licence from KTU to develop this unique and patented technology. This innovative solution in the field of health has not gone unnoticed internationally.

For more information on the ThrombUS+ project, please visit the project website: thrombus.eu.